Amid the ongoing public skepticism about the pricing of Covishield vaccine, the Serum Institute of India (SII) on Saturday said only a limited portion of its vaccines will be sold to private hospitals at Rs 600 per dose.

In a statement, the company said, in light of the current dire situation, it has to ensure sustainability and must be able to invest in scaling up and expanding the production capacity.

“Only a limited portion of Serum Institute of India’s volume will be sold to private hospitals at Rs 600 per dose. The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat COVID19 and other life-threatening diseases,” SII said in a statement.

Share on Facebook

Tweet

Follow us